Your session is about to expire
← Back to Search
Chemotherapy for Childhood Leukemia, Lymphoma, or Solid Cancers
Study Summary
This trial is testing a new cancer drug to see if it is effective in treating young patients with leukemia, lymphoma, or solid tumors.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Find a Location
Who is running the clinical trial?
Media Library
- I haven't had cancer in the last 5 years, except for skin cancer.My cancer has returned or is not responding to treatment and has spread to the lining of my brain or spinal cord.My kidney function is good, with creatinine below 1.5 mg/dL.My liver function tests are within normal limits.I have had a condition where my lymphocytes grow abnormally.I am not pregnant or nursing, use birth control, and don't have uncontrolled illnesses except HIV.I am between 1 and 21 years old.I have a history of cancer.I am able to get out of my bed or chair and move around.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How extensively is this trial being conducted in U.S. healthcare facilities?
"Subjects are being sought from six specific medical facilities, such as the Texas Children's Cancer Center in Houston and University of Texas Southwestern Medical Centre at Dallas. Additionally, Alberta Children's Hospital in Calgary is taking part along with three other sites."
To whom is this research opportunity available?
"To qualify for this research program, candidates should have a diagnosis of leukemia and be aged 1-21. Approximately 15 participants are needed to complete the trial."
Has this therapy gained regulatory approval by the FDA?
"Due to the limited amount of evidence supporting efficacy and safety, our team has assigned a score of 1. This is an indication that this trial is in Phase 1."
Is there currently an opportunity for volunteers to join this trial?
"Clinicaltrials.gov indicates that this trial is no longer actively enrolling patients, as the study was posted on February 1st 1997 and last edited on March 22nd 2010. However, there are currently 5068 other clinical trials still in search of participants."
Is there an age restriction for participation in this research?
"This clinical trial seeks individuals between the ages of 1 year and 21 years."
Share this study with friends
Copy Link
Messenger